Growth Metrics

Insulet (PODD) EBT Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 797.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 797.00
Dec 31, 2025 1,186.00
Sep 30, 2025 1,906.00
Jun 30, 2025 1,643.00
Mar 31, 2025 -339.00
Dec 31, 2024 843.00
Sep 30, 2024 973.00
Jun 30, 2024 2,139.00
Mar 31, 2024 1,231.00
Dec 31, 2023 2,868.00
Sep 30, 2023 668.00
Jun 30, 2023 -50.00
Mar 31, 2023 818.00
Dec 31, 2022 278.00
Sep 30, 2022 -225.00
Jun 30, 2022 -1,313.00
Mar 31, 2022 892.00
Dec 31, 2021 363.00
Sep 30, 2021 429.00
Jun 30, 2021 -990.00
Mar 31, 2021 517.00
Dec 31, 2020 -219.00
Sep 30, 2020 746.00
Jun 30, 2020 1,467.00
Mar 31, 2020 840.00
Dec 31, 2019 1,189.00
Sep 30, 2019 368.00
Jun 30, 2019 598.00
Mar 31, 2019 1,603.00
Dec 31, 2018 2,542.00
Sep 30, 2018 2,636.00
Jun 30, 2018 2,746.00
Mar 31, 2018 1,659.00
Dec 31, 2017 -268.00
Sep 30, 2017 1,271.00
Jun 30, 2017 3,337.00
Mar 31, 2017 -92.00
Dec 31, 2016 -477.00
Sep 30, 2016 3,172.00
Jun 30, 2016 1,240.00
Mar 31, 2016 528.00
Dec 31, 2015 -132.00
Sep 30, 2015 -250.00
Jun 30, 2015 -26.00
Mar 31, 2015 922.00
Dec 31, 2014 2,747.00
Sep 30, 2014 1,598.00
Jun 30, 2014 1,995.00
Mar 31, 2014 2,606.00
Dec 31, 2013 7,125.00
Sep 30, 2013 1,270.00
Jun 30, 2013 4,247.00